Allergy Immunotherapy Market is growing at a swift pace 10.85% of CAGR till 2023 | Along with Foremost Vendors like ALK Abello A/S, DBV Technologies, Stallergenes Greer & others

“Allergy Immunotherapy Market”
“Global Allergy Immunotherapy Market” report of Market Research Future explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Drivers, Restraints, Opportunities, Challenges, Macroeconomic Indicators and Technology Trends & Assessment.

Allergy Immunotherapy Market – Insights:

Market Research Future (MRFR)’s latest report reveals that the global allergy immunotherapy market is set to exhibit a steep rise in growth registering a CAGR of 10.85% during the forecast period 2017 to 2023. The market has been estimated to reach a valuation of USD 4,324.7 Mn by the end of 2023.

The widespread prevalence of allergies has fueled demand in the allergy immunotherapy market. The trend is anticipated to perpetuate over the next couple of years. According to a report published by the World Health Organization (WHO), approximately 10-40% of the population was suffering from allergy in 2013.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/1517

The increasing patient pool coupled with the availability of advanced allergy treatment procedures has augured well for the players of the allergy immunotherapy market. The market is expected to remain highly lucrative in the foreseeable future, and the increased investments in clinical trials and research & development activities are set to catapult the market on an upward trajectory.

The developing healthcare sector in emerging markets in Latin America, Asia, etc. are anticipated to steer the growth of the allergy immunotherapy market. Other favorable factors encouraging the growth of the market include increasing awareness of the treatment, technological advancement, growth strategies of major players, etc.

Allergy Immunotherapy Market -Competitive Dashboard:

ALK Abello A/S

DBV Technologies

Stallergenes Greer

HAL Allergy Group

Allergy Therapeutics

Merck KGaA

And Circassia (UK) among others.

Allergy Immunotherapy Market – Segmentation:

By allergy type, the global allergy immunotherapy market has been segmented into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. The allergic rhinitis segment currently accounts for a dominant share of the market. Meanwhile, the peanut allergy segment is estimated to register a CAGR of 11.3%.

Ask Any Question at https://www.marketresearchfuture.com/check-discount/1517

By treatment, the allergy immunotherapy market is segmented into Subcutaneous Immunotherapy (SCIT), sublingual immunotherapy, and Specific Immunotherapy (SIT). The Subcutaneous Immunotherapy (SCIT) segment holds the largest share of the market and is projected to reach a valuation of USD 2,089.2 by 2023.

Industry Developments:

In August 2018, Arrayit Corporation, life sciences, and personalized medicine company announced its partnership with multiple providers of allergen immunotherapy products for allergy testing to treat patients with allergy and asthma.

In August 2018, Astria Sunnyside Hospital announced the availability of an allergy testing and treatment program. Allergy treatment options being offered at the hospital include sublingual immunotherapy and regular allergy shots.

Allergy Immunotherapy Market – Regional Analysis:

By region, the global allergy immunotherapy market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Europe accounts for the maximum share of the market and is expected to retain a significant share of the market towards the end of the assessment period. Led by Western Europe, the factors favoring the growth of the regional market are increasing patient pool, rising healthcare expenditure, etc.

Americas market is estimated to reach a valuation of USD 1,409.6 Mn by 2023. The growth is attributable to the increasing awareness regarding treatment of allergies and high prevalence of allergic rhinitis & skin allergy.

Asia Pacific is projected to register a CAGR of 11.32% during the forecast period. Meanwhile, the U.A.E. currently holds 53.5% share of the Middle East & Africa market and resonates strong opportunities for growth.

Check Discount Here at https://www.marketresearchfuture.com/check-discount/1517

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517